ATE338543T1 - Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase- inhibitor sowie deren verwendung - Google Patents

Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase- inhibitor sowie deren verwendung

Info

Publication number
ATE338543T1
ATE338543T1 AT04742296T AT04742296T ATE338543T1 AT E338543 T1 ATE338543 T1 AT E338543T1 AT 04742296 T AT04742296 T AT 04742296T AT 04742296 T AT04742296 T AT 04742296T AT E338543 T1 ATE338543 T1 AT E338543T1
Authority
AT
Austria
Prior art keywords
compositions containing
superoxide dismutase
lipoxygenase inhibitor
allergy
lipoxygenase
Prior art date
Application number
AT04742296T
Other languages
English (en)
Inventor
Bernard Dugas
Original Assignee
Isocell S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell S A filed Critical Isocell S A
Application granted granted Critical
Publication of ATE338543T1 publication Critical patent/ATE338543T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
AT04742296T 2003-03-28 2004-03-19 Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase- inhibitor sowie deren verwendung ATE338543T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0303865A FR2852847B1 (fr) 2003-03-28 2003-03-28 Composition renfermant une superoxyde dismutase et un inhibiteur de la 5-lipoxygenase selectionne et applications

Publications (1)

Publication Number Publication Date
ATE338543T1 true ATE338543T1 (de) 2006-09-15

Family

ID=32947258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04742296T ATE338543T1 (de) 2003-03-28 2004-03-19 Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase- inhibitor sowie deren verwendung

Country Status (6)

Country Link
EP (1) EP1608351B1 (de)
KR (1) KR20050119083A (de)
AT (1) ATE338543T1 (de)
DE (1) DE602004002292T2 (de)
FR (1) FR2852847B1 (de)
WO (1) WO2004087119A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2645674A1 (en) 2006-03-15 2007-09-20 Isocell Pharma S.A. Pharmaceutical compositions comprising sods and prolamine based peptide fragments
FR2899065B1 (fr) * 2006-03-29 2008-07-18 Alain Dreyer Brevets Et Dev So Sod micro encapsulee et adsorbee sur support mineral et vegetal destinee a l'alimentation animale
KR100852864B1 (ko) * 2007-04-13 2008-08-18 보령메디앙스 주식회사 초록입 홍합(Ｐｅｒｎａ Ｃａｎａｌｉｃｕｌｕｓ.)추출물을 함유하는 화장료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695456A (en) * 1984-10-31 1987-09-22 Centerchem, Inc. Method for alleviating skin irritation by formulations containing superoxide dismutase
EP0366869A3 (de) * 1988-10-17 1991-06-12 Lycon Ag Bakteriostatische,Bakterizide und Pilzabweisende Zusammensetzung und Verwendung derselben
LU87766A1 (fr) * 1990-07-20 1992-03-11 Oreal Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
US5561052A (en) * 1992-06-18 1996-10-01 Koike; Katsumasa Process for detecting oxidized lipids and process for forming oxidized lipids

Also Published As

Publication number Publication date
KR20050119083A (ko) 2005-12-20
WO2004087119A2 (fr) 2004-10-14
WO2004087119A3 (fr) 2004-12-09
FR2852847A1 (fr) 2004-10-01
EP1608351B1 (de) 2006-09-06
DE602004002292D1 (de) 2006-10-19
EP1608351A2 (de) 2005-12-28
DE602004002292T2 (de) 2007-09-13
FR2852847B1 (fr) 2006-09-08

Similar Documents

Publication Publication Date Title
WO2004052280A3 (en) Anti-angiogenic compounds and their use in cancer treatment
SE0102315D0 (sv) Compounds
CL2004000437A1 (es) Compuestos heterociclicos del tipo [1,4]-diazepan-2-ona sustituidos, inhibidores de la enzima dipeptidilpeptidasa-iv (cdp-iv); composicion farmaceutica; y su uso para preparar un medicamento para tratar hiperglucemia, diabetes tipo 2, obesidad, trast
TW200714604A (en) Substituted heterocycles and the uses thereof
NO20060978L (no) Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
WO2002092026A3 (en) Dermatological and cosmetic compositions
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
GEP20125565B (en) Lactam compounds and their pharmaceutical use
WO2006110809A3 (en) Nanoparticulate lipase inhibitor formulations
WO2004060890A8 (en) 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
NO20055130D0 (no) Aminocykloheksyleter-forbindelser og deres anvendelse
WO2004045557A3 (en) Novel lapachone compounds and methods of use thereof
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
ATE338543T1 (de) Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase- inhibitor sowie deren verwendung
ATE353231T1 (de) Pharmazeutische zusammensetzungen
DE602006003224D1 (de) Substituierte heterocyclen, ihre verwendung als medikament und pharmazeutische zubereitungen, die sie enthalten
PT1838716E (pt) Di-hidrato de pamoato de olanzapina
ATE457779T1 (de) Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte
PT1594456E (pt) Utilização de uma composição contendo óxido de vitamina k1 ou um seu derivado para tratamento e/ou prevenção de lesões dermatológicas em mamíferos
WO2006128740A3 (en) Anti-vascular methods and therapies employing lysyl oxidase inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties